首页> 外文期刊>European urology >Robotic-Assisted Laparoscopic Intracorporeal Urinary Diversion
【24h】

Robotic-Assisted Laparoscopic Intracorporeal Urinary Diversion

机译:机器人辅助腹腔镜体内泌尿

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Recent small case series have now been reported for robotic-assisted laparoscopic radical cystectomy (RALRC). In most of these series, the urinary diversion has been performed in an extracorporeal fashion. There have been few case reports of an intracorporeal diversion and little description of the technique of such a procedure. Objective: In this paper, we report our initial experience with robotic-assisted laparoscopic intracorporeal urinary diversion, describing stepwise the surgical procedure itself and evaluating perioperative and pathologic outcomes of this novel procedure. Design, setting, and participants: We studied a single-institution case series of patients undergoing robotic-assisted cystectomy and intracorporeal urinary diversion for clinically localized urothelial carcinoma of the bladder (n = 10) or for a noncompliant dysfunctional bladder refractory to more conservative management (n = 2). Historical comparisons are also made to a consecutive case series of 20 patients undergoing robotic radical cystectomy and extracorporeal urinary diversion. Surgical procedure: RALRC and intracorporeal urinary diversion, including ileal conduit (n = 9) and orthotopic ileal neobladder (n = 3). Measurements: The stepwise operative procedure is described in detail. Outcome measures evaluated in this series included operative variables, hospital recovery, and complication rate. Comparisons were made to a contemporaneous series of 20 patients who underwent a robotic cystectomy with extracorporeal diversion during this time period (from an experience of >100 robotic cystectomy patients since 2005). Results and limitations: Twelve patients (mean age: 60.9 yr) underwent an intracorporeal diversion. Mean operating-room time of all patients was 5.3 h, and mean surgical blood loss was 221 ml. Mean time to flatus, bowel movement, and hospital discharge was 2.2 d, 3.2 d, and 4.5 d, respectively. Eleven of the 12 patients were discharged on or before postoperative day 5. There were six postoperative complications in five patients (42%), with one complication being Clavien grade 3 or higher. The major limitations of the study are the small sample size and the nonrandomized nature of the compared treatment groups (intracorporeal vs extracorporeal), which limits the ability to directly compare the techniques at a high level of scientific confidence. Conclusions: Our initial experience with robotic-assisted laparoscopic intracorporeal. diversion appears to be favorable with acceptable operative and short-term clinical outcomes.
机译:背景:最近报道了机器人辅助腹腔镜根治性膀胱切除术(RALRC)的小病例系列。在这些系列中的大多数中,导尿都是通过体外方式进行的。几乎没有关于体内转移的病例报道,也很少描述这种方法的技术。目的:在本文中,我们报告了我们在机器人辅助的腹腔镜体内尿路改道方面的初步经验,逐步描述了手术过程本身,并评估了这种新方法的围手术期和病理结果。设计,地点和参与者:我们研究了单机构病例系列患者,这些患者因机械定位的膀胱尿路上皮癌(n = 10)或因不合规的功能障碍性膀胱难治而接受更保守的治疗,因此接受了机器人辅助膀胱切除术和体内尿路改道(n = 2)。还对连续进行的20例行机器人根治性膀胱切除术和体外导尿的患者进行了历史比较。外科手术:RALRC和体内尿液改道,包括回肠导管(n = 9)和原位回肠新膀胱(n = 3)。测量:详细描述逐步操作程序。该系列评估的结果指标包括手术变量,医院恢复情况和并发症发生率。对同期进行的一系列20例行膀胱膀胱切除术并进行体外转移的患者进行了比较(自2005年以来,已有100多例机器人膀胱切除术患者入选)。结果与局限性:12例患者(平均年龄:60.9岁)经历了体内转移。所有患者的平均手术时间为5.3 h,平均手术失血量为221 ml。肠胀气,排便和出院的平均时间分别为2.2 d,3.2 d和4.5 d。术后第5天或之前12例患者中有11例出院。5例患者中有6例术后并发症(42%),其中1例并发症为Clavien 3级或更高。该研究的主要局限性是样本量小和所比较的治疗组(体内与体外)的非随机性质,这限制了以较高的科学可信度直接比较技术的能力。结论:我们在机器人辅助腹腔镜体内试验的初步经验。转移似乎对手术和短期临床效果均可接受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号